ATC Group: M01AB16 Aceclofenac

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M01AB16 in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M01 Antiinflammatory and antirheumatic products
3 M01A Antiinflammatory and antirheumatic products, non-steroids
4 M01AB Acetic acid derivatives and related substances
5 M01AB16 Aceclofenac

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.2 g

Active ingredients in M01AB16

Active Ingredient Description

Aceclofenac is a non-steroidal agent with marked anti-inflammatory and analgesic properties. The mode of action of aceclofenac is largely based on the inhibition to prostaglandin synthesis. Aceclofenac is a potent inhibitor of the enzyme cyclo-oxygenase, which is involved in the production of prostaglandins.

Medicines in this ATC group

Brazil (BR)

Cyprus (CY)

Estonia (EE)

France (FR)

Germany (DE)

Ireland (IE)

Italy (IT)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

Poland (PL)

Romania (RO)

Singapore (SG)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.